U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT07556107) titled 'The Vancomycin Piperacillin/Tazobactam (VPT) Patient Safety Trial (VPS)' on Feb. 03.
Brief Summary: The VPT Safety Trial (VPS) compares two common antibiotic combinations to see how they affect the kidneys of patients in the hospital with serious infections. Both combinations are approved by the Food and Drug Administration (FDA). The goal is to help doctors know which combination is safer so they can make better choices for their patients.
Study Start Date: June 01
Study Type: INTERVENTIONAL
Condition:
Infection
Acute Kidney Injury
Sepsis
Intervention:
DRUG: Piperacillin + Tazobactam
PT Dosing (concealed): PT dosing is stan...